|
|
此文章由 jeremyOTZ 原创或转贴，不代表本站立场和观点，版权归 oursteps.com.au 和作者 jeremyOTZ 所有！转贴必须注明作者、出处和本声明，并保持内容完整
bradcherry 发表于 2021-8-6 17:08 
感谢您的回复
你说：
1，“这个疫苗对早期的新冠病毒是有效的”
我本没有义务去浪费我自己的闲暇时间去给你搜数字。哪怕你稍微关注相关新闻都能知道大致的保护率。
好人做到底，我随手Google了一下证明我的论点是可信的。就这样，你杠就是你对。
1，“这个疫苗对早期的新冠病毒是有效的”
请问这个结论出自哪里
https://www.pfizer.com/news/pres ... cacy-and-no-serious
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced updated topline results from analysis of 927 confirmed symptomatic cases of COVID-19 observed in their pivotal Phase 3 study through March 13, 2021, showing the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, was 91.3% effective against COVID-19, measured seven days through up to six months after the second dose. The vaccine was 100% effective against severe disease as defined by the U.S. Centers for Disease Control and Prevention (CDC), and 95.3% effective against severe COVID-19 as defined by the U.S. Food and Drug Administration (FDA). Safety data from the Phase 3 study has also been collected from more than 12,000 vaccinated participants who have a follow-up time of at least six months after the second dose, demonstrating a favorable safety and tolerability profile.
2，大致是被感染的风险减半（不会携带病毒），几乎不会转重症和死亡
请问风险减半的说法出自哪里，“几乎”不会是什么意思，打了疫苗不会转重症和死亡的数据到底是多少
https://www.nejm.org/doi/full/10.1056/NEJMoa2108891
Effectiveness after one dose of vaccine (BNT162b2 or ChAdOx1 nCoV-19) was notably lower among persons with the delta variant (30.7%; 95% confidence interval [CI], 25.2 to 35.7) than among those with the alpha variant (48.7%; 95% CI, 45.5 to 51.7); the results were similar for both vaccines. With the BNT162b2 vaccine, the effectiveness of two doses was 93.7% (95% CI, 91.6 to 95.3) among persons with the alpha variant and 88.0% (95% CI, 85.3 to 90.1) among those with the delta variant. With the ChAdOx1 nCoV-19 vaccine, the effectiveness of two doses was 74.5% (95% CI, 68.4 to 79.4) among persons with the alpha variant and 67.0% (95% CI, 61.3 to 71.8) among those with the delta variant.
3，目前的数据显示是会被感染，但是几乎不会转重症和死亡。副作用如心肌炎和血栓的概率极低。
请问目前的数据是指哪个数据，出处。
同上，其余媒体和官方网站也可以找到相近的数据。
请问概率极低是多低，有数值吗及出处
Pfizer心肌炎
https://www.health.com/condition ... mmation-myocarditis
However, early data for adolescents and young adults ages 12 to 39 suggests that these problems are occurring at a rate of 12.6 per million doses.
AZ血栓
https://www.health.gov.au/initia ... e-cause-blood-clots
| Age | Estimated risk of TTS per 100,000 AstraZeneca vaccine doses (first dose) | | <50 years | 3.1 | | 50-59 years | 2.7 | | 60-69 years | 1.4 | | 70-79 years | 1.8 | | 80+ years | 1.9 |
4，我不担心副作用。全澳上千万人接种，出现副作用的寥寥
同上 |
评分
-
查看全部评分
|
我读过的一本好书 － 陈慧的《拾香记》 (2011-8-31) astina 
楼主:bradcherry
发表于 2021-8-6 17:09
